#ÀÎõ¾ÆÅäÇÇÇѾà, #ÀÎõ¾ÆÅäÇÇÇѾàÇÑÀÇ¿ø, #¾ÆÅäÇÇÁø¹°, #ÀÎõ¾ÆÅäÇÇÁø¹°, #¾ÆÅäÇÇÇѾàÇÑÀÇ¿ø, #¾ÆÅäÇÇÁø¹°ÇÑÀÇ¿ø, #ÀÎõ¾ÆÅäÇÇÁø¹°, #û¶ó¾ÆÅäÇÇÇѾà
ÀÎõ¾ÆÅäÇÇÇѾà,,ÀÎõ¾ÆÅäÇÇÇѾàÇÑÀÇ¿ø,,¾ÆÅäÇÇÁø¹°,,ÀÎõ¾ÆÅäÇÇÁø¹°,,¾ÆÅäÇÇÇѾàÇÑÀÇ¿ø,,¾ÆÅäÇÇÁø¹°ÇÑÀÇ¿ø,,ÀÎõ¾ÆÅäÇÇÁø¹°,,û¶ó¾ÆÅäÇÇÇѾà
¾È³çÇϼ¼¿ä. ÀÎõ¾ÆÅäÇÇÇѾà û¶ó ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä
ÀÎõ¾ÆÅäÇÇÇѾà û¶ó Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ÀÎõÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â¾ÆÅäÇÇÁø¹°, ¼Ò¾Æ¾ÆÅäÇÇ, ¾ÆÅäÇÇ, ¾ÆÅäÇǾà, Å¿, ¾Æ±â¾ÆÅäÇÇÇǺο°, ¾ÆÅäÇǶ¡¶ì, ¾î¸¥¾ÆÅäÇÇ, ¾ÆÅäÇǰǼ±, ¾ÆÅäÇÇÄ¡·á, ¾ÆÅäÇÇÇѾà, ¾ÆÅäÇÇ°ü¸®, ¼Õ¾ÆÅäÇÇ, µî¾ÆÅäÇÇ, ¾î¸°À̾ÆÅäÇÇ, ¼Õ°¡¶ô¾ÆÅäÇÇ, ÀÓ»êºÎ¾ÆÅäÇÇ, ÆȲÞÄ¡¾ÆÅäÇÇ, ¾Æ±â¾ÆÅäÇÇÁõ»ó, ´«¾ÆÅäÇÇ, °¡½¿¾ÆÅäÇÇ, ¿µ¾Æ¾ÆÅäÇÇ, ¾Æ±â¾ó±¼¾ÆÅäÇÇ, ¾ÆÅäÇÇÇǺΰú, ¸ñ¾ÆÅäÇÇµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù.
¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó ôÃß°ßÀÎÄ¡·á, ¹ß¸ñº¸È£´ë, Àû¿Ü¼±Ä¡·á, MSAT, LASER, TENS, Ȳ·ÃÇص¶ÅÁ¾àħ, ÁßdzÁ¶±â°ËÁø, ÁÂÈÆ¿ä¹ý, ¿Â¿Ä¡·á, Àδë°È¿îµ¿, ÀιٵðÃøÁ¤, ÀÌħ, ÇѹæÁ¾ÇÕ°ËÁø, ³ì¿ë¾àħ, FES, ¾óÀ½¿åÁ¶, ¾óÀ½¸¶»çÁö, ¿À°ø¾àħ, ÅëÁõÄ¡·á±â, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù
¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼ Áø·áÁßÀ̸ç Ãæ³² ºÎ¿©±º È«»ê¸é, ÀÎõ ¿¬¼ö±¸ ¼Ûµµ2µ¿, ÃæºÏ ÃæÁֽà ´ë¼Ò¿ø¸é, ºÎ»ê °¼±¸ ´ëÀú2µ¿, °¿ø Ⱦ¼º±º ¼¿ø¸é, °æºÏ ¾Èµ¿½Ã ¼®µ¿µ¿, ºÎ»ê »çÇϱ¸ ½ÅÆò1µ¿, °æ±â ½ÃÈï½Ã ½ÃÈï¿ìü±¹»ç¼ÇÔ, °æºÏ ¾Èµ¿½Ã ÀÏÁ÷¸é, ºÎ»ê Áß±¸ Áß¾Óµ¿2°¡, ÀÎõ ³²±¸ ¿ëÇö2µ¿, °æ³² â¿ø½Ã ÁøÇر¸ ȸÇöµ¿, °æºÏ ¾Èµ¿½Ã ¼®µ¿µ¿, Ãæ³² û¾ç±º ¸ñ¸é, ¿ï»ê ¿ïÁÖ±º û·®¸é, ºÎ»ê °¼±¸ ´ëÀú2µ¿, ºÎ»ê Áß±¸ ºÎ»ê¿ìü±¹»ç¼ÇÔ, ºÎ»ê ¿¬Á¦±¸ °ÅÁ¦3µ¿, °¿ø µ¿Çؽà ȿ°¡µ¿, ºÎ»ê ºÎ»êÁø±¸ °¡¾ß3µ¿, °æ³² »çõ½Ã »ïõÆ÷¿ìü±¹»ç¼ÇÔ, °æºÏ Æ÷Ç׽à ³²±¸ ÀÏ¿ùµ¿, °æºÏ ¾Èµ¿½Ã dzõ¸é, Àü³² ¿©¼ö½Ã Çп뵿, °æ³² â¿ø½Ã ÀÇⱸ ÅðÃ̵¿, °æ³² °í¼º±º ¿µ¿À¸é, Á¦ÁÖ Á¦Áֽà ÀÌÈ£À̵¿, °æ±â ¾È¾ç½Ã µ¿¾È±¸ ºñ»ê3µ¿, Ãæ³² û¾ç±º Á¤»ê¸é, ÀÎõ ¿¬¼ö±¸ ¼Ûµµµ¿, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼ ³»¿øÇÏ°í °è½Ê´Ï´Ù
ÀÎõ¾ÆÅäÇÇÇѾàÄ¡·á ãÀ¸½Ã´Â À²¸ñµ¿, ÀÎõ¼±¸, ¸Å¼Û¸é, ¼®³²µ¿, µ¿±¸, ½ÃÈï, ¼Ò·¡Æ÷±¸, ´ëºÎµµ, °Ë´Ü, ¼þÀǵ¿, ¿ëÀ¯µµ, ³íÇö°íÀܵ¿, ¿î¼µ¿, Áß±¸, °Ë¾Ï, ±¸¿ùµ¿, ÀÛÀüµ¿, ³²¾çÀ¾, ûÇе¿, ¿¬Èñµ¿, ¼Ûµµ½Åµµ½Ã, ¿¬¼ö±¸, Á־ȵ¿, ÆÈź¸é, ¿ëÇöµ¿, ¿µÈïµµ, ¼Ã¢µ¿, ¼Û»ê¸é, ¸¸¼öµ¿, ÀÎõ³íÇö, ¼Ûµµ, ¼Ûµµ±¹Á¦µµ½Ã, ¿Á·Ãµ¿, ÀÎõÁÖ¾È, °è»êµ¿ µî ÀÎõ Áö¿ª Áֹε鲲¼ ¹Ì¿ÃÇÑÀÇ¿øÀÎõÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù.
´õ »ìÆ캸±â
1. Hui RL, Lide W, Chan J, et al. Association between exposure to topical tacrolimus or pimecrolimus and cancers. Ann Pharmacother 2009; 43:1956.
2. Gonzalez ME, Schaffer JV, Orlow SJ, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol 2016; 75:481.
3. Reitamo S, Wollenberg A, Schöpf E, et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 2000; 136:999.
4. Wollenberg A, Sharma S, von Bubnoff D, et al. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol 2001; 107:519.
5. Camargo CA Jr, Ganmaa D, Sidbury R, et al. Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children. J Allergy Clin Immunol 2014; 134:831.
6. Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol 2014; 134:818.
7. Jekler J, Larkö O. Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: a paired-comparison study. J Am Acad Dermatol 1990; 22:49.